Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/16/2006 | US20060257431 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
11/16/2006 | US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle |
11/16/2006 | US20060257424 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines |
11/16/2006 | US20060257423 Hepatitis B vaccine (HeVac) and Bacille Calmette-Guerin (BCG); cryoprotectants; lyophilization; heat stability; tuberculosis |
11/16/2006 | US20060257419 Bordetella pertussis antigen consisting lipopolysaccharide, pertusis toxin, filamentous hemagglutinin, pertactin or abosrbed to alum; interleukin-12 ; enhances cell-mediated immunity in a host |
11/16/2006 | US20060257418 Vaccine |
11/16/2006 | US20060257416 Materials and methods for improved vaccination |
11/16/2006 | US20060257415 Adjuvants |
11/16/2006 | US20060257414 Mycoplasma gallisepticum formulation |
11/16/2006 | US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
11/16/2006 | US20060257372 Improvements in ruminants such as increased milk production, feedlot performance, growth rate, decrease in finishing time, lower digestive morbidity and mortality, lower incidence of lactic acidosis |
11/16/2006 | US20060257329 Delivery of drug esters through an inhalation route |
11/16/2006 | CA2609296A1 Nanoparticulate and controlled release compositions comprising a cephalosporin |
11/16/2006 | CA2608326A1 Pteridines useful as hcv inhibitors and methods for the preparation thereof |
11/16/2006 | CA2608301A1 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
11/16/2006 | CA2608061A1 Pharmaceutical composition including an anti-tumoral and an active ingredient selected among carveol, thymol, eugenol, borneol and carvacrol |
11/16/2006 | CA2608058A1 Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
11/16/2006 | CA2607806A1 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
11/16/2006 | CA2607617A1 Thiazole compounds and methods of use |
11/16/2006 | CA2607561A1 Pharmaceutical composition |
11/16/2006 | CA2607421A1 Thienopyrroles as antiviral agents |
11/16/2006 | CA2607293A1 Use of tfpi to treat severe bacterial infections |
11/16/2006 | CA2607145A1 Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria |
11/16/2006 | CA2607143A1 Delivery of tigecycline in the presence of heparin |
11/16/2006 | CA2606890A1 Immunogens for meningitidis-a vaccines |
11/16/2006 | CA2606887A1 Pharmaceutical composition |
11/16/2006 | CA2606875A1 Pharmaceutical combination including an antibiotic and an active ingredient selected among carveol, thymol, carvacrol, alpha-ionone and beta-ionone |
11/16/2006 | CA2606847A1 Antibacterial agents |
11/16/2006 | CA2606507A1 Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate |
11/16/2006 | CA2586250A1 Compositions for treating respiratory viral infections and their use |
11/15/2006 | EP1721987A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
11/15/2006 | EP1721981A1 Recombinant varicella-zoster virus |
11/15/2006 | EP1721906A1 3-pyridinium methylcephem compound |
11/15/2006 | EP1721901A1 Abc transporter inhibitor |
11/15/2006 | EP1721898A1 Quinoline and pyridoquinoxaline derivatives as antibacterial agents |
11/15/2006 | EP1721618A2 Proteosome influenza vaccine composition |
11/15/2006 | EP1721614A1 Epirubicine hydrochloride for treating hepatitis C virus |
11/15/2006 | EP1720899A2 Multimerised hiv fusion inhibitors |
11/15/2006 | EP1720889A1 Sulfated oligosaccharide derivatives |
11/15/2006 | EP1720876A1 Crystalline forms of valacyclovir hydrochloride |
11/15/2006 | EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
11/15/2006 | EP1720578A2 Bacteriostatic esters for topical use |
11/15/2006 | EP1720570A2 Treatment of dengue hemorrhagic fever |
11/15/2006 | EP1720524A2 Extended release tablets of clarithromycin |
11/15/2006 | EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
11/15/2006 | EP1427718B1 Benzothiepine ileal bile acid transport inhibotors |
11/15/2006 | EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
11/15/2006 | EP1363925B1 Macrolide antibiotics |
11/15/2006 | EP1326610B1 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
11/15/2006 | EP1324991B1 Compounds useful in the treatment of inflammatory diseases |
11/15/2006 | EP1286696B1 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
11/15/2006 | EP1272197B1 Combination of lecithin with ascorbic acid |
11/15/2006 | EP1254659B1 Stable emulsion compositions |
11/15/2006 | EP1222281B1 Immunoligically significant herpes simplex virus antigens |
11/15/2006 | EP1208214B1 Genetically engineered bleb vaccine |
11/15/2006 | EP1132391B1 Process for the preparation of 3-sulfonyloxy-3-cephem compounds |
11/15/2006 | EP1093363B1 Compositions for treatment of disorders associated with chlamydia |
11/15/2006 | EP1039921B1 Substantially pure histidine-linked protein polymer conjugates |
11/15/2006 | EP1009430B1 Oil in water emulsion vaccines against Hepatitis B |
11/15/2006 | CN1864434A Wireless microphone communication system |
11/15/2006 | CN1863813A Novel tricyclic nucleosides or nucleotides as therapeutic agents |
11/15/2006 | CN1863812A Polymorphic antiviral nucleoside compounds |
11/15/2006 | CN1863801A Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of HIV and inflammation |
11/15/2006 | CN1863788A Substances of antimicrobial, antifungoid and antiprotozoan activities |
11/15/2006 | CN1863771A Sequence selective pyrrole and imidazole polyamide metallocomplexes |
11/15/2006 | CN1863535A Noncrystalline antibacterial composition containing cefditoren pivoxil |
11/15/2006 | CN1863533A No title available |
11/15/2006 | CN1863528A Indoles and azaindoles as antiviral agents |
11/15/2006 | CN1863524A Neutralizing agent for cavitating toxin |
11/15/2006 | CN1861634A Dog interferon alpha, preparation process and use thereof |
11/15/2006 | CN1861626A Metallic salt kind medicine containing glycyrrhizic hypoglycyrrhizic or its derivant and preparation process thereof |
11/15/2006 | CN1861623A Asparagic acid azithromycin and preparation thereof |
11/15/2006 | CN1861622A Macrocyclolactone lactone kind medicine erythromycin A derivant, synthesizing process and use thereof |
11/15/2006 | CN1861621A Process of preparing burdock glucoside and glucosidgen thereof |
11/15/2006 | CN1861608A Crystalline solvate of cefuroxime acid |
11/15/2006 | CN1861599A Quinone carboxylic acid kind derivant, it preparation process and medicine application |
11/15/2006 | CN1861582A Cyclopropyl substituded triazol kind anti fungus compound and preparation process and use thereof |
11/15/2006 | CN1861195A Fowl vaccine immunopotentiator of chicken interleuken-18, and its application |
11/15/2006 | CN1861191A Application of human sDR5 protein as medicine to treat virus hepatitis B |
11/15/2006 | CN1861189A Medicinal composition for eliminating infection and reduplication of influenza-virus |
11/15/2006 | CN1861188A Aerosol contg. met-enkephalin |
11/15/2006 | CN1861177A Medicinal composition for treating children cold and its prepn. process |
11/15/2006 | CN1861131A Qingkailing dixinwan pill prepn. and its prepn. method |
11/15/2006 | CN1861120A Oral liquor contg. Boehmeria nivea |
11/15/2006 | CN1861107A Thin coating medicine for treating cold and its prepn. method |
11/15/2006 | CN1861106A Compound isatis root effervescent tablet and its prepn. method |
11/15/2006 | CN1861105A Traditional Chinese medicine used for treating human papillomavirus infection |
11/15/2006 | CN1861092A Application of chlorine-contg. disinfectant in pharmaceutics |
11/15/2006 | CN1861084A Compound fluorophenylnico injection, prepn. method and use thereof |
11/15/2006 | CN1861079A Compounding prepn. contg. cefteram pivoxil and pidotimod |
11/15/2006 | CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
11/15/2006 | CN1861065A Formula and prepn. method for compound ointment contg. zinc undecenate |
11/15/2006 | CN1861062A Medicine composition used for fish or other aquatic livings and its prepn. method |
11/15/2006 | CN1861044A Voriconazole injection and its prepn. method |
11/15/2006 | CN1284854C Mosaic type DNA vaccine in use for preventing tuberculosis and immunological therapy |
11/15/2006 | CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell |
11/15/2006 | CN1284798C Poly thymosin-alpha 1, its composition, its preparation method and application |
11/15/2006 | CN1284786C Glycyrrhetic acid and phospholipid composites of glycyrrhetate and process for preparing same |
11/15/2006 | CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
11/15/2006 | CN1284763C Compound for preparing protease inhibitor |